CDK4/6 Inhibitor Resistant Breast Cancer Models

Leverage our extensive panel of CDK4/6 inhibitor resistant breast cancer models, including: 

  • In vitro induced Palbociclib resistant MCF-7 cell line
  • In vivo induced Palbociclib resistant MCF-7 model
  • In vivo induced Abemaciclib resistant MCF-7 model
  • In vivo induced Ribociclib resistant MCF-7 model

View additional drug-resistant models in our platform

WuXi AppTec CDK4_6 inhibitor resistant models-Newsletter


← Return to Resources
× peptide, amino acid

Contact An Expert Today!